NDC product
INJECTION, SUSPENSION · Cilag AG
NDC 12502-5500 · Cilag AG
Key facts
| Product NDC | 12502-5500 |
|---|---|
| Nonproprietary name | rilpivirine hydrochloride |
| Substances | RILPIVIRINE HYDROCHLORIDE |
| Dosage form | INJECTION, SUSPENSION |
| Labeler | Cilag AG |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Jan 21, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: